Leigh Anne Siino on The Spherix Global’s Translation of ASH25 Insights Into Actionable Intelligence
Leigh Anne Siino, Chief Revenue Officer at Spherix Global Insights, shared on LinkedIn:
”The Spherix Global Insights Hematology/Oncology team is translating key insights from ASH25 into actionable intelligence — helping strategy, commercial, and medical teams across pharma prepare for the next wave of change across benign and malignant hematology.
What we’re seeing and why it matters now:
Sickle Cell Disease: Turning Patient Voice and Data Into Advantage
SCD is entering a pivotal period, with growing emphasis on coordinated patient-level data and deeper incorporation of patient perspectives.
As pipelines advance and treatment options expand, organizations with timely, centralized insights will be best positioned to optimize targeting, prepare for launches, and align strategies with real-world care delivery.
Cross-Therapeutic Mechanisms and Gene Therapy in Benign Hematology
ASH underscored rising interest in therapies with shared mechanisms across conditions — including autoimmune cytopenias, SCD, hemophilia, and vWD — alongside continued focus on gene therapies.
These dynamics reinforce the need for cross-therapy intelligence to support faster, evidence-based decision-making as indications evolve.
Malignant Hematology: Next-Gen Modalities and Earlier-Line Opportunity
In malignant disease, advances in CAR-T platforms, expanding AML pipelines, and movement into earlier lines (including smoldering multiple myeloma) are reshaping both clinical and commercial landscapes.
Explore our latest and upcoming hematology publications on the Spherix Client Portal.”
All from ASH25 featured in Hemostasis Today.
-
Feb 19, 2026, 16:01Honoring Black Pioneers in Hematology During Black History Month – ASH
-
Feb 19, 2026, 15:16Irina Pahlevanyan: Global Leaders on Courage, Trust, and the True Purpose of Fundraising
-
Feb 19, 2026, 15:12Stéphanie Forté: Transition Readiness in Youth With Sickle Cell Disease
-
Feb 19, 2026, 15:08Tagreed Alkaltham: Strengthening Blood Inventory Governance Through RFID Technology
-
Feb 19, 2026, 14:59Başak Taburoğlu Yılmaz: Improving Diagnosis and Care for Women With Bleeding Disorders
-
Feb 19, 2026, 14:59Munira Borhany: Moving Beyond Stereotypes in the Diagnosis of Bleeding Disorders
-
Feb 19, 2026, 14:56Flora Peyvandi: Personalized VWF Dosing Revolutionizes Surgery in VWD
-
Feb 19, 2026, 14:54Michela Mazzon: The Molecular Trigger Behind the COVID19 Vaccines-Associated ITT
-
Feb 19, 2026, 14:42Luca Palombi: Real-Time Assessment of Venous Hemodynamics During Movement With DUS